Posted on

EyePromise Restore Got an Upgrade

Over the years, science has made incredible discoveries and improvements. Food trends have also changed. From cutting carbs to slashing sugars, nutrition has become an important part of a healthier life. Nutraceuticals have also adapted with the times to include ingredients recently found to be beneficial. As an innovative leader, EyePromise® has been on the forefront of these improvements and was the first to utilize dietary zeaxanthin and Vitamin D in eye health nutraceuticals. EyePromise has reviewed recent scientific developments and has decided it’s time for its flagship formula, Restore, to get an upgrade.

What’s New?

Based on cutting-edge research, EyePromise has added vitamins B6 and B12, folate, and CoQ10 to Restore. The clinical evidence supports the benefits of these nutrients for age-related eye health concerns.

Vitamins B6 and B12 and folate CoQ10


B Vitamins

Vitamin B6, Vitamin B12, and folate have been proven to work together to reduce age-related eye health issues. A randomized trial whose participants were women with a high risk of cardiovascular disease showed that supplementation with folic acid (folate) and vitamins B6 and B12 may reduce the risk of age-related eye health issues. Another study linked elevated levels of homocysteine in the blood with age-related eye health concerns, and vitamins B6 and B12 and folic acid help to reduce the level of homocysteine.


CoQ10CoQ10 protects the mitochondria, the powerhouse of retinal cells.

As an antioxidant, CoQ10 protects the mitochondria, the powerhouse of the retinal cells. These cellular pieces are usually the first affected by eye health concerns. Oxidation in the retina begins with defective mitochondria, and oxidative damage is what instigates the decline of vision, especially with age-related eye health concerns.

New & Improved Restore vs. AREDS 2 formulas

With the new ingredients, a high level of dietary zeaxanthin (8 mg), and other ingredients proven to support aging eyes, Restore is the best formula to proactively reduce the risk of age-related eye health issues. EyePromise Restore is a proactive formula designed for patients concerned with, at risk for, or with early signs of age-related eye health concerns. The AREDS 2 study formula proved effective for slowing the progression of intermediate to advanced AMD.

EyePromise Restore is a proactive formula for patients with AMD risk.

Risks for Age-Related Eye Health Issues


  • Family history of age-related eye health concerns
  • Age
  • Light skin and eyes
  • Female


Scientific Support

The original EyePromise Restore formula has been proven effective in several clinical studies, and the new ingredients will only complement the impressive results. For example, John Herman, OD, FAAO, completed a 2-year, 521-patient study testing Restore’s impact on macular pigment optical density, visual function, and age-related eye health issues. With enhancements in structure and function, the researchers found that:

Dr. John Herman's results with the original Restore formula were impressive.

This visionary nutrition gives your patients a way to enhance their visual function while protecting their long-term vision. Restore offers your patients the premium protection their aging eyes need. Don’t be reactive with eye health. Be proactive with EyePromise Restore. Order now.

See what Dr. Paul Chous has to say about the new formula.




  1. Merle, Bénédicte MJ et al. “Dietary Folate, B Vitamins, Genetic Susceptibility and Progression to Advanced Nonexudative Age-Related Macular Degeneration with Geographic Atrophy: A Prospective Cohort Study.” The American Journal of Clinical Nutrition 103.4 (2016): 1135–1144. PMC. Web. 18 Jan. 2018.
  2. Huang, Peirong et al. “Homocysteine and the Risk of Age-Related Degeneration: A Systematic Review and Meta-Analysis.” Scientific Reports 5 (2015): 10585. PMC. Web. 18 Jan. 2018.
  3. Christen, William G. et al. “Folic Acid, Vitamin B6, and Vitamin B12 in Combination and Age-Related Macular Degeneration in a Randomized Trial of Women.” Archives of internal medicine 169.4 (2009): 335–341. PMC. Web. 18 Jan. 2018.
  4. Elevated Serum Homocysteine, Low Serum Vitamin B12, Folate, and Age-related Macular Degeneration: The Blue Mountains Eye Study, Rochtchina, Elena et al. American Journal of Ophthalmology , Volume 143 , Issue 2 , 344 – 346
  5. Kamburoglu, Gunhal, et al. “Plasma Homocysteine, Vitamin B12 and Folate Levels in Age-Related Macular Degeneration.” Graefe’s Archive for Clinical and Experimental Ophthalmology, vol. 244, no. 5, 2005, pp. 565–569., doi:10.1007/s00417-005-0108-2.
  6. Blasi M, A, Bovina C, Carella G, Genova M, L, Jansen A, M, A, Lenaz G, Brancato R, Does Coenzyme Q10 Play a Role in Opposing Oxidative Stress in Patients with Age-Related Macular Degeneration? Ophthalmologica 2001; 215:51-54
  7. Juan Garrido-Maraver, Mario D. Cordero, Manuel Oropesa-Avila, Alejandro Fernandez Vega, Mario de la Mata, Ana Delgado Pavon, Elisabet Alcocer-Gomez, Carmen Perez Calero, Marina Villanueva Paz, Macarena Alanis, et al. “Clinical applications of coenzyme Q10”. Front Biosci (Landmark Ed) 2014; 19: 619–633. Published online 2014 Jan 1.
  8. Riazi-Esfahani, Mohammad, Baruch D. Kuppermann, and M. Cristina Kenney. “The Role of Mitochondria in AMD: Current Knowledge and Future Applications.” Journal of Ophthalmic & Vision Research 12.4 (2017): 424–428. PMC. Web. 15 Jan. 2018.
  9. Sears, Al. “Can CoQ10 Save Your Vision?” The Wellness Blog, US Wellness Meats, 29 Aug. 2013,